Home/Tag: TKD

Invivoscribe Announces FDA Approval for Distribution of the LeukoStrat CDx FLT3 Mutation Assay as an IVD Kit in the United States

2020-05-19T16:22:45+00:00May 19th, 2020|Categories: Press Releases|Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |

⟵  PRESS RELEASES PRESS RELEASE SAN DIEGO, [...]

Invivoscribe Submits LeukoStrat® CDx FLT3 Mutation Assay to NMPA in China and Expands Company, Adding Laboratory in Shanghai to Provide Comprehensive Support for Partners.

2020-05-12T17:03:17+00:00May 12th, 2020|Categories: Press Releases|Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |

⟵  PRESS RELEASES PRESS RELEASE SAN DIEGO, [...]